Subscribe for great stories in your community!
Currently there is no U.S. Food and Drug Administration-approved medicine for nonalcoholic steatohepatitis, also referred to as NASH.
NASH is a fatty liver…
Inovio Pharmaceuticals has received a $7 million milestone payment from MedImmune. The payment is part of a license and collaboration agreement, valued at up to…
Before we send you to this site, please subscribe to our daily newsletter.